Comparison of O-specific polysaccharide responses in patients following infection with
O-specific polysaccharide
Vibrio cholerae O139
cholera
immune response
oral cholera vaccine
Journal
mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533
Informations de publication
Date de publication:
24 10 2023
24 10 2023
Historique:
medline:
27
10
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
ppublish
Résumé
Cholera caused by
Identifiants
pubmed: 37646517
doi: 10.1128/msphere.00255-23
pmc: PMC10597347
doi:
Substances chimiques
Cholera Vaccines
0
O Antigens
0
Lipopolysaccharides
0
Vaccines, Inactivated
0
Antibodies, Bacterial
0
Immunoglobulin A
0
Immunoglobulin M
0
Blood Group Antigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Intramural
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0025523Subventions
Organisme : NIH HHS
ID : AI099243
Pays : United States
Organisme : FIC NIH HHS
ID : TW010362
Pays : United States
Organisme : NIH HHS
ID : AI106878
Pays : United States
Organisme : NIH HHS
ID : AI137164
Pays : United States
Organisme : Intramural NIH HHS
Pays : United States
Organisme : FIC NIH HHS
ID : TW005572
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW005572
Pays : United States
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8433-8
pubmed: 10880560
Lancet Infect Dis. 2018 Jun;18(6):666-674
pubmed: 29550406
Am J Trop Med Hyg. 2014 May;90(5):873-81
pubmed: 24686738
Eur J Biochem. 1995 Sep 1;232(2):391-6
pubmed: 7556186
Trop Med Infect Dis. 2021 Oct 27;6(4):
pubmed: 34842841
Annu Rev Microbiol. 2022 Sep 8;76:681-702
pubmed: 35759873
J Infect Dis. 1994 Sep;170(3):701-4
pubmed: 8077733
Mol Microbiol. 1996 Feb;19(4):815-26
pubmed: 8820651
J Clin Microbiol. 2014 Apr;52(4):1146-52
pubmed: 24452176
Carbohydr Res. 1996 Aug 26;290(1):59-65
pubmed: 8805782
Appl Environ Microbiol. 2006 Jun;72(6):4096-104
pubmed: 16751520
mBio. 2021 Apr 20;12(2):
pubmed: 33879588
Protein Sci. 1993 Jul;2(7):1106-13
pubmed: 8358294
J Infect Dis. 2004 Jun 15;189(12):2318-22
pubmed: 15181581
Clin Diagn Lab Immunol. 2000 May;7(3):444-50
pubmed: 10799459
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11388-92
pubmed: 7972070
Emerg Infect Dis. 2003 Sep;9(9):1116-22
pubmed: 14519249
J Infect Dis. 2011 Sep 15;204(6):912-8
pubmed: 21849288
Hybridoma (Larchmt). 2011 Feb;30(1):19-28
pubmed: 21466282
PLoS Negl Trop Dis. 2021 Sep 2;15(9):e0009721
pubmed: 34473699
Epidemiol Infect. 2015 Aug;143(11):2330-42
pubmed: 25496520
PLoS Negl Trop Dis. 2019 Aug 1;13(8):e0007634
pubmed: 31369553
J Clin Microbiol. 2019 Apr 26;57(5):
pubmed: 30814268
Epidemiol Infect. 1995 Feb;114(1):71-3
pubmed: 7867745
Nat Commun. 2022 Jul 5;13(1):3864
pubmed: 35790755
Lancet. 1993 Aug 14;342(8868):387-90
pubmed: 8101899
Emerg Infect Dis. 2013 Oct;19(10):1713-5
pubmed: 24050113
J Infect Dis. 1994 May;169(5):1029-34
pubmed: 8169387
Infect Immun. 2005 Oct;73(10):6577-83
pubmed: 16177333
J Bacteriol. 1995 Feb;177(3):835-8
pubmed: 7836323
Lancet. 2012 Jun 30;379(9835):2466-2476
pubmed: 22748592
Glycoconj J. 2000 Jun;17(6):425-33
pubmed: 11294508
Biochemistry. 2002 Nov 19;41(46):13575-86
pubmed: 12427018
Clin Diagn Lab Immunol. 1997 May;4(3):264-9
pubmed: 9144361
Infect Immun. 1997 Sep;65(9):3571-6
pubmed: 9284121
Chemistry. 2019 Oct 8;25(56):12946-12956
pubmed: 31306528
N Engl J Med. 2016 May 5;374(18):1723-32
pubmed: 27144848
Lancet. 1993 Mar 13;341(8846):703-4
pubmed: 8095620
J Biol Chem. 1998 Jan 30;273(5):2777-83
pubmed: 9446585
Carbohydr Res. 1996 Aug 26;290(1):43-58
pubmed: 8805781
Vaccine. 2020 Feb 11;38(7):1753-1761
pubmed: 31879124
mSphere. 2021 Aug 25;6(4):e0011421
pubmed: 34232076
Clin Vaccine Immunol. 2012 Nov;19(11):1712-21
pubmed: 22993410
PLoS Negl Trop Dis. 2015 Nov 12;9(11):e0004183
pubmed: 26562418
Biochem Biophys Res Commun. 1993 Jan 15;190(1):302-7
pubmed: 8422256
J Immunol. 1987 Jun 15;138(12):4419-27
pubmed: 2438343